Mergers & Acquisition: Key Strategy of Market Players in the Global Breast Biopsy Market

The global breast biopsy market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period (2021-2027). The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace. For instance, in January 2021, Hologic, Inc. had acquired Somatex Medical Technologies GmbH for around $64 million. Somatex’s products include minimally invasive devices for tumor diagnostics, biopsy, and interventional specialties that will assist Hologic Inc., as an opportunity to expertise its breast cancer portfolio. 

Browse the full report description of "Global Breast Biopsy Market Size, Share & Trends Analysis Report by Type (Fine Needle Biopsy, Core Needle Biopsy, Surgical Biopsy, and Others (Lymph Node and Vacuum-Assisted Biopsy)), By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kit, and Other), By Guided Technology (MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography Guided Stereotactic Biopsy, CT-Guided Biopsy and Other), By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/breast-biopsy-market

Further, in January 2020, OncoCyte Corp., a molecular diagnostic company had acquired Insights Genetics, Inc. (IG) which has an impactful innovation in the areas of lung and breast cancer. Besides, in January 2019, IZI Medical products had acquired breast localization needle assets from Cook Medical. The acquired portfolio of products is commercially marketed under the Quick-Core Biopsy Needle, MReye Breast Localisation Coil, and the Kopans and X-Reidy Lesion Localisation Needles. Thus, the mergers & acquisitions by the major key players for the expansion of the product portfolio is fostering the breast biopsy market during the forecast period. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Type

o By Product

o By Guided Technology

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape-Becton, Dickson and Co., Danaher Corp., Hologic, Inc., QIAGEN GmbH, F. Hoffman-La Roche Ltd., Argon Medical Devices, Inc., Cigna International, and others

Key Strategies Adopted by Major Players:

• In July 2020, NeoGenomics announced the launch of three liquid biopsy tests for advanced non-small cell lung cancer (NSCLC), certain breast cancer tumors, and all solid tumors. The new test includes InVisionFirst-Lung, NeoLAB Solid Tumor Liquid Biopsy will assist the physician to deliver information regarding tumors.
• In April 2019, Hologic Inc. had launched the Trident HD specimen radiography system in the US. This has expanded the product portfolio of the company. This product has increased image consistency and streamline the sample verification process during breast-conserving procedures and stereotactic breast biopsies. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Breast Biopsy Market Report Segment

By Type

• Fine Needle Biopsy
• Core Needle Biopsy
• Surgical Biopsy
• Others (Lymph Node and Vacuum-Assisted Biopsy)

By Product

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kit
• Other 

By Guided Technology

• MRI-Guided Biopsy
• Ultrasound-Guided Biopsy
• Mammography Guided Stereotactic Biopsy
• CT-Guided Biopsy
• Other

By End-User

• Hospitals
• Diagnostic Centre
• Research Institute

Global Breast Biopsy Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/breast-biopsy-market